$2.3M
5 filings since 2025 · latest SAFE filed
Phio Pharmaceuticals Corp. is a biotechnology company specializing in the development of groundbreaking therapeutics, particularly in the field of immuno-oncology. Utilizing their proprietary technology platform, they focus on addressing unmet medical needs to potentially enhance cancer treatment outcomes.
What sets it apart
What sets Phio Pharmaceuticals apart is their proprietary technology platform that supports both independent and collaborative therapeutic developments, leveraging intellectual property to maintain a competitive edge in the field.
PH-762 is the flagship product candidate of Phio Pharmaceuticals, currently in clinical studies. It shows promising potential in enhancing cancer treatment by modulating immune responses to improve therapy outcomes.
